June 5, 2012 — Hansen Medical Inc. received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for ...
Peripheral Artery Disease (PAD)
This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.
June 05, 2012
May 23, 2012 - Boston Scientific Corp. announces U.S. Food and Drug Administration approval and market launch of the ...
May 23, 2012May 17, 2012 — Boston Scientific Corp. announces CE mark and European market launch of the Innova Self-Expanding Bare ...
May 17, 2012Self-Expanding, Balloon-Expandable Stents Perform Well in Real-World Peripheral Artery Disease Study
May 14, 2012 -- Two types of stent systems are both effective in treating patients who have severe forms of peripheral ...
May 14, 2012
May 4, 2012 - Angioslide Ltd., a provider of embolic capture angioplasty solutions, announced that it has received U.S ...
May 04, 2012May 4, 2012 - A new balloon catheter system could advance the endovascular approach to treating obstructed arteries in ...
May 04, 2012
April 17, 2012 –– Expanding its commitment to developing innovative treatments for cardiovascular disease and the ...
April 17, 2012
March 16, 2012 — The U.S. Food and Drug Administration (FDA) approved the premarket approval (PMA) application for the ...
March 16, 2012
March 9, 2012 — Avinger Inc. announced the enrollment of the first U.S. patient in the CONNECT II global clinical trial ...
March 09, 2012
March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) t ...
March 06, 2012
March 6, 2012 — Vascular Magnetics announced it has raised $7 million to advance development of a drug delivery system ...
March 06, 2012
February 9, 2012 — Boston Scientific announced the United States launch of the TruePath CTO device, designed to ...
February 09, 2012January 18, 2012 — Boston Scientific reported nine-month clinical endpoint data from its ORION trial, demonstrating ...
January 18, 2012
January 13, 2012 — Amorcyte Inc.,a NeoStem Inc. company, announced the expansion of intellectual property protection ...
January 13, 2012
December 22, 2011 – Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe ...
December 22, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now